Vimarsana
Biggest News Aggregation in the World

Functional Neurosurgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional Neurosurgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Neurosurgery Today - Breaking & Trending Today

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System - Vimarsana News

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

SOLANA BEACH, Calif., June 01, 2024 -- ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announces full...

ClearPoint Neuro Announces Full Market Release of - Vimarsana News

ClearPoint Neuro Announces Full Market Release of

Newly Launched ClearPoint Neuro technology - SmartFrame OR and Prism Laser will be on display at ASSFN in Nashville from June 1 - 4...

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo - Vimarsana News

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

SOLANA BEACH, Calif., Jan. 24, 2024 -- ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced...

Neoleukin Therapeutics : Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome - Form 8-K -December 19, 2023 at 07:34 am EST - Vimarsana News

Neoleukin Therapeutics : Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome - Form 8-K -December 19, 2023 at 07:34 am EST

Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome Two pediatric patients with Rett...

AI, Ozempic and noncompetes: The trends to watch in 2024 - Vimarsana News

AI, Ozempic and noncompetes: The trends to watch in 2024

As 2023 comes to a close and orthopedic and spine specialists, CEOs and administrators nationwide are setting their sights on 2024, there are a few key trends that the majority of industry professionals are focusing on.